98% Salvianolic Acid Powder Salvia Miltiorrhiza Extract CAS 115939-25-8 Salvianolic Acid B

• Customization: Available
• Certification: RoHS, BRC, ISO, FDA, HACCP
• Assay Method: HPLC-MS, GPC, HPLC, UV
• Model NO.: C82
• Application Form: Injection, Lotion, Suppository, Paste, Tablet, Capsule
• Application: Food, Health Care Products, Medicine
• State: Powder
• Extract Source: Salvia Miltiorrhiza Extract
• Name: Salvianolic Acid B
• Appearance: Brown Powder
• Assay: 98%
• CAS: 115939-25-8
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Transport Package: Foil Bag
• Specification: 98
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Salvianolic acid B
Appearance	Brown Powder
CAS NO.	115939-25-8
Storage	Keep in a cool, dry, dark location

 

Salvianolic acid B is a naturally occurring polyphenolic compound primarily isolated from the root of Salvia miltiorrhiza (Danshen), a traditional Chinese medicinal herb. It belongs to the class of salvianolic acids, which are water-soluble phenolic acids characterized by a unique structure combining caffeic acid and danshensu moieties. Salvianolic acid B is renowned for its potent antioxidant, anti-inflammatory, and cardioprotective properties, making it a key bioactive constituent in Danshen extracts studied for its therapeutic potential in cardiovascular and neurodegenerative diseases.

 

1. Cardiovascular Protection:
   • Used in formulations targeting myocardial ischemia, atherosclerosis, and hypertension due to its ability to improve coronary blood flow and inhibit platelet aggregation.
   • Investigated for reducing oxidative stress-induced endothelial dysfunction, a precursor to cardiovascular disorders.
2. Neuroprotective Agent:
   • Applied in preclinical studies for neurodegenerative conditions like Alzheimer's and Parkinson's disease, where it mitigates neuronal apoptosis and inflammation.
   • Explored for its role in enhancing cerebral microcirculation and protecting against ischemic stroke-related damage.
3. Anti-Fibrotic Therapy:
   • Evaluated in liver and renal fibrosis models for its inhibitory effects on collagen deposition and activation of hepatic stellate cells.

1. Antioxidant Activity:
   • Scavenges reactive oxygen species (ROS) and upregulates endogenous antioxidant enzymes (e.g., SOD, glutathione peroxidase).
   • Prevents lipid peroxidation and DNA damage, thereby reducing oxidative injury in tissues.
2. Anti-Inflammatory Effects:
   • Inhibits NF-κB signaling and downstream pro-inflammatory cytokines (e.g., TNF-α, IL-6) to alleviate chronic inflammation.
   • Modulates macrophage polarization toward an anti-inflammatory M2 phenotype, promoting tissue repair.
3. Vasoprotective and Thrombolytic Properties:
   • Enhances nitric oxide (NO) bioavailability, promoting vasodilation and endothelial integrity.
   • Interferes with platelet adhesion and aggregation pathways, reducing thrombotic risk in cardiovascular settings.